HealthSource logo

HealthSource Review

Best for: compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy. Starting from $199/month for semaglutide, each subscription covers the cost of medication, supplies, a telehealth visit with a board-certified physician, and unlimited provider messaging through a HIPAA-compliant platform. Services are available in all 50 US states with direct-to-door delivery in 3–5 business days.

By Eli Marsden · Founding Editor
Editorially reviewed (not clinically reviewed) · How we verify contentLast reviewed
6.5
★★★☆☆3.3
CompoundedSemaglutideTirzepatideOral Tirzepatide503A Pharmacy50-state coverage24/7 provider messagingBoard-certified physicians
$199/mo

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

The Bottom Line

HealthSource is a solid telehealth option with balanced features and pricing.

Score: 6.5/10Best for: compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/moFrom: $199/mo
HealthSource logo
3.3 / 5
Our editorial rating
Visit HealthSource

from $199/mo · no insurance needed

HealthSource at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Oral Tirzepatide
Starting price
$199/mo (Verbatim from product page: 'From: $199.00 every 4 weeks.' Medication is compounded semaglutide+B12 in vial form with syringes and alcohol pads. Multiple dose tiers available (Full Dose, Starter 4-week, Starter 6-week, 8-week); $199 is entry-tier price.)
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored HealthSource

Each dimension is scored algorithmically from HealthSource’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

5.7/10

At $199/mo, HealthSource runs about 17% above the $170 median for GLP-1 providers.

Effectiveness25%

7.1/10

HealthSource offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

6.7/10

Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.

Trust & Safety15%

6.9/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-07-04).

Accessibility10%

7.2/10

HealthSource treats patients in all 50 states.

Support10%

5.3/10

Clinician messaging between visits.

How we verified this HealthSource review

Last checked 2026-07-04
  • Confirmed current pricing across 3 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

GLP-1 medications HealthSource offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

All dosesCompounded
$199/mo
semaglutide

Verbatim from product page: 'From: $199.00 every 4 weeks.' Medication is compounded semaglutide+B12 in vial form with syringes and alcohol pads. Multiple dose tiers available (Full Dose, Starter 4-week, Starter 6-week, 8-week); $199 is entry-tier price.

All dosesCompounded
$299/mo
tirzepatide

Verbatim from product page: 'From: $299.00 every 4 weeks.' Injectable tirzepatide dispensed through 503A partner pharmacy. Multiple dose tiers available; $299 is entry-tier price.

Oral sublingualCompounded
$399/mo
tirzepatide

Verbatim from product page: 'From: $399.00 every 4 weeks.' Oral sublingual tirzepatide tablet taken once daily before bed; ships in 5–10 business days. $399 is entry-tier price.

Ready to get started?

Plans and promotions change often — check HealthSource's current pricing and active discounts before you decide.

See HealthSource pricing →

What we like

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Watch-outs

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Is HealthSource worth it? Our verdict

HealthSource positions itself around one thing: compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo. It runs $199/month — a premium to the category, so the extras need to justify it. Its standout is a needle-free oral option, which very few providers offer.

Beyond the core GLP-1 program, HealthSource leans on Oral Tirzepatide, 503A Pharmacy, and 50-state coverage.

How much HealthSource actually costs

  • Compounded semaglutide — $199/month
  • Compounded tirzepatide — $299/month
  • Compounded tirzepatide — $399/month

For context, the typical ongoing price across the GLP-1 providers we track is around $170/month, so HealthSource's standing rate sits at the premium end.

For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against HealthSource before you commit.

Medications: what HealthSource prescribes

HealthSource prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.

HealthSource's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.

Who HealthSource is best for — and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option.
  • live anywhere in the US and want guaranteed access.
  • value being able to message a clinician between visits.

Look elsewhere if you…

  • want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
  • specifically want an FDA-approved brand-name pen.
  • need to bill insurance — like most of this market, it's cash-pay.

Trust, safety, and medical oversight

HealthSource treats patients in all 50 states, offers clinician messaging between visits, and dispenses through an accredited compounding pharmacy. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

HealthSource costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.

Ready to start with HealthSource?

Starting at $199/month. See current pricing and start your free consultation.

Alternatives to HealthSource

8.6/ 10
Verified partner

Enhance MD

Best for: lab-monitored compounded GLP-1 with mandatory video visit

★★★★4.3

Editorial score · methodology

$49/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Enhance MD review →
8.5/ 10
Verified partner

Embody

Best for: lowest first-month entry pricing on compounded GLP-1s

★★★★4.3

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Embody review →
8.5/ 10
Verified partner

TrimRx

Best for: best overall value

★★★★4.3

Editorial score · methodology

$179/mo
CompoundedSemaglutide
Get StartedRead full TrimRx review →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this HealthSource review:

Sources & methodology — as of July 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

Ready to start with HealthSource?

Starting at $199/month. See current pricing and start your free consultation.